Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Overview of attention for article published in New England Journal of Medicine, March 2023
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Mentioned by
- news
- 81 news outlets
- blogs
- 2 blogs
- policy
- 1 policy source
- 331 X users
- patent
- 1 patent
- 1 Facebook page
- wikipedia
- 4 Wikipedia pages
- 2 Redditors
- video
- 1 YouTube creator
- guideline
- 10 clinical guideline sources
- podcasts
- 3 podcasts
Readers on
- mendeley
- 400 Mendeley